We are live on
!
Find out more
NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.23B
1-Year Est. Return
81.32%
This Fund
S&P 500
This Quarter
Est. Return
+5.32%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$1.6B
AUM Growth
-$496M
(-24%)
Cap. Flow
-$440M
Cap. Flow
% of AUM
-27.44%
Top 10 Holdings %
Top 10 Hldgs %
54.93%
Holding
55
New
3
Increased
15
Reduced
6
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Disc Medicine
IRON
|
+$117M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$17.4M |
| 3 |
BLU
BELLUS Health Inc.
BLU
|
+$15.8M |
| 4 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
+$15.2M |
| 5 |
Rallybio
RLYB
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$501M |
| 2 |
ACLX
Arcellx
ACLX
|
+$39.2M |
| 3 |
Brookfield
BN
|
+$20M |
| 4 |
Milestone Pharmaceuticals
MIST
|
+$18.4M |
| 5 |
Boston Scientific
BSX
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 69.58% |
| 2 | Technology | 18.99% |
| 3 | Financials | 4.49% |
| 4 | Communication Services | 4.18% |
| 5 | Consumer Discretionary | 2.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Milestone Pharmaceuticals
MIST
$152M
| – | – |
-2,000,000
| Closed | -$18.4M |
|
52
Nkarta
NKTX
$172M
| – | – |
-823,200
| Closed | -$10.8M |
|
|
53
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
| – | – |
-1,525,550
| Closed | -$501M |
|
|
UTRS
54
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| – | – |
-93,144
| Closed | -$17.2M |
|
|
SPNE
55
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| – | – |
-525,867
| Closed | -$2.99M |
|
Similar funds
MP
FLII
IC
IA
HTHT
BCP
SPC
SC
Novo Holdings A/S's Q4 2022 Portfolio in Review
As of Q4 2022, Novo Holdings A/S held 55 positions worth $1.6B, down 24% from $2.1B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Novo Holdings A/S withdrew a net $440M in Q4 2022, closing 7 positions and reducing 6 holdings. Its most notable exit was Vanguard Morningstar Total Stock Market ETF, an estimated $501M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
Against the trend, Novo Holdings A/S opened a new position in Disc Medicine worth $46.6M.
- Novo Holdings A/S's largest Q4 2022 buy was Disc Medicine: 2,340,772 shares worth $46.6M.
- Novo Holdings A/S added most to Seagen Inc. Common Stock in Q4 2022, an estimated $17.4M increase.
- Novo Holdings A/S's biggest Q4 2022 reduction was Arcellx, cutting an estimated $39.2M.
- Novo Holdings A/S fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2022, selling an estimated $501M.
- Novo Holdings A/S's ten largest holdings make up 55% of its $1.6B portfolio in Q4 2022.
- Novo Holdings A/S opened 3 new positions and closed 7 in Q4 2022.
- Novo Holdings A/S's portfolio value fell 24% quarter-over-quarter to $1.6B.
Based on Novo Holdings A/S's 13F filing for Q4 2022, filed 14 Feb 2023.